Click Here to return To Results

 

Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019 See this aricle in Pubmed Article Abstract Fremanezumab was effective and well tolerated in patients with difficult-to-treat migraine who had previously not responded to up to four classes of migraine preventive medications.

Related Tags

(click to filter results - removes previous filter) efficacy fremanezumab migraine migraine,prophylaxis migraine,treatment of monoclonal antibodies prevention of neurologic disorders safety treatment of neurologic disorder

Click Here to return To Results